Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol - Wikidata - awgldk - TriplyDB

Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol

Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol

http://www.wikidata.org/entity/Q28297779

about

Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines Myositis ossificans circumscripta, secondary to high-velocity gunshot and fragment wound that causes sciatica Shaping the military wound: issues surrounding the reconstruction of injured servicemen at the Royal Centre for Defence Medicine.Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.Heterotopic ossification following hip arthroplasty: a comparative radiographic study about its development with the use of three different kinds of implants.HO prevention and the combined therapeutic protocol--do we really need it?Nontraumatic Myositis Ossificans of Hip: A Case Presentation.Prophylaxis of heterotopic ossification - an updated review.Impact of surgical approach on postoperative heterotopic ossification and avascular necrosis in femoral head fractures: a systematic review.Heterotopic ossifications following implant surgery--epidemiology, therapeutical approaches and current concepts.Identifying the Cellular Mechanisms Leading to Heterotopic Ossification.DEGRO practical guidelines for the radiotherapy of non-malignant disorders - Part IV: Symptomatic functional disorders.Classifications in brief: Brooker classification of heterotopic ossification after total hip arthroplasty.Elevated levels of numerous cytokines in drainage fluid after primary total hip arthroplasty.Is fixation an option for comminuted femoral head fracture?Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty.Post-Traumatic Heterotopic Ossification: An Old Problem in Need of New Solutions.Severe heterotopic ossifications after Rockwood type II acromioclavicular joint injury: a case report.Treatments and Preventative Measures for Trauma-Induced Heterotopic Ossification: A Review.

P2860

Q28083665-89DFCA45-BC01-41D2-993A-48D3252B8911 Q28300425-50FDD130-EB71-4D47-A81E-245EE5AAD21A Q34454803-59324651-4E98-473E-99BB-1F4C2CDBE1DD Q34459614-3E3780C1-B342-417C-9199-3CF32692112E Q36278581-C988D628-B902-4605-B382-39555D4EED47 Q36495742-180E6B58-9FCC-4A26-9CFD-AA06E1B39A0A Q37089084-6264320C-F91D-4BED-813A-FFF0D6E05451 Q37451829-3E04904F-F546-4085-9718-F73D67BD1C3B Q37579722-4D8A863E-9296-4929-A174-6E87CB459684 Q37829358-667105F5-F052-4B0E-8397-4EBE2930A5A2 Q38545114-5C5C0FCC-9959-4DC0-ADA8-450E94BBE4E6 Q39197478-A06B1B08-2EED-4C4A-89F0-454B93035BB5 Q40242426-5AC08317-A58A-4D39-89F4-F7599DDCECB7 Q41694682-ADBED218-9261-4AC1-900A-AB9434865DC5 Q41981182-6A6EDA41-57A5-4A93-9DA7-1812EF7603B1 Q44195290-A2CA79B9-FAAC-42C1-8783-B49E9EC20873 Q47296118-070001A4-1089-4439-8B19-86372FBF117A Q47608242-A5B7DCC5-DF59-40DC-9528-ECCE7A8EE8CA Q55686756-9BC2E14A-6D27-475C-83EC-5C47AE1C195D

P2860

Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol

http://www.wikidata.org/entity/Q28297779

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Prevention of heterotopic ossi ...... combined therapeutic protocol

@ast

Prevention of heterotopic ossi ...... combined therapeutic protocol

@en

Prevention of heterotopic ossi ...... combined therapeutic protocol

@nl

type

label

Prevention of heterotopic ossi ...... combined therapeutic protocol

@ast

Prevention of heterotopic ossi ...... combined therapeutic protocol

@en

Prevention of heterotopic ossi ...... combined therapeutic protocol

@nl

prefLabel

Prevention of heterotopic ossi ...... combined therapeutic protocol

@ast

Prevention of heterotopic ossi ...... combined therapeutic protocol

@en

Prevention of heterotopic ossi ...... combined therapeutic protocol

@nl

P1433

Q28297779-EFAF233F-BC0F-4754-899E-EAD62949899E

P1476

Q28297779-0A876D6C-9127-44D4-AB45-5A605EB05D02

P2093

Q28297779-59CBF6C7-8538-47ED-A3A6-995B3C73DE83

Q28297779-7D1C4BDA-3AEE-426A-B376-57105108E96A

Q28297779-A4113163-8A4E-4139-A509-990CEC35FA3B

Q28297779-A81F66ED-8279-4943-B447-F751C81E6E03

Q28297779-D8B7728C-2F1D-4329-AF61-7BA6222EEE33

Q28297779-F9133A96-5208-4EDC-A2AC-96E8BF280FF0

P2860

Q28297779-07A1C575-12C8-4CFB-8C36-CCA4A5B2F154

Q28297779-0E9FD330-5FA9-4533-8432-D03B4AE6CACF

Q28297779-173E3DDC-76F6-455A-94B2-AE1CA8B6AE95

Q28297779-2CCFB1F6-876C-430D-975A-7CF16ECFEEA4

Q28297779-3CAAB7AA-2E5B-4D07-A1A1-7AC61D9C7F9C

Q28297779-5E7A4992-7730-49A9-A48F-1F819F9899C0

Q28297779-5FF622D1-8542-4CBE-B40A-0536194186C8

Q28297779-610A67C7-AC68-4C7C-9A63-0DF470DDAD07

Q28297779-69E3F57C-5EE8-45A1-A9C3-0FDF19AFA339

Q28297779-6D943AC9-CD0D-40EB-A4FE-3BD52A6D8270

P2888

Q28297779-90931A7A-338C-4958-8BC5-726F30F018B5

P304

Q28297779-ABEA99C1-40EA-4369-8657-153DC397F5DF

P31

Q28297779-CB610CDD-9998-44E0-AF60-9D0BBCA8FDFB

P3181

Q28297779-459C0BFA-699D-4C31-9D20-CB551FA300E9

P356

Q28297779-6FD530F6-C410-469F-8449-ABB2209CA1A5

P407

Q28297779-1FAD1E56-EF75-4342-9012-390C74370EAD

P433

Q28297779-704ACFCC-E802-4F4B-ABD3-65757FFF6F6A

P478

Q28297779-EFC89329-6F99-4B1B-9AD7-3FEE7CAD8C13

P577

Q28297779-CE594FF0-A082-4BE5-AD6E-D4678EAC966F

P5875

Q28297779-8C6FD3E6-DBFD-4A0F-BE61-3915A3F863DE

P6179

Q28297779-2B16FE52-FAD1-46F9-9E1A-52C7065087D2

P698

Q28297779-CFA09D05-2C0B-4192-AE71-BD66495F4B02

P921

Q28297779-C00BDE87-33D5-4B39-895F-DB02FD3560C2

P932

Q28297779-D4E1689A-090F-4167-B4B1-CF3FFC83752F

P3181

P356

S00264-005-0054-Y

P1433

International Orthopaedics

P1476

Prevention of heterotopic ossi ...... combined therapeutic protocol

@en

P2093

Emilios E Pakos

http://www.w3.org/2001/XMLSchema#string

Evita J Pitouli

http://www.w3.org/2001/XMLSchema#string

Kosmas Stafilas

http://www.w3.org/2001/XMLSchema#string

Pericles G Tsekeris

http://www.w3.org/2001/XMLSchema#string

Theodore H Xenakis

http://www.w3.org/2001/XMLSchema#string

Vasiliki Papathanasopoulou

http://www.w3.org/2001/XMLSchema#string

P2860

Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty

Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials

Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation

Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment.

Preoperative, single-fraction irradiation for prophylaxis of heterotopic ossification after total hip arthroplasty.

Para-articular ossification following hip replacement. 70 arthroplasties ad modum Moore using McFarland's approach.

Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty.

Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.

Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.

Ectopic ossification following total hip replacement. Incidence and a method of classification.

P2888

s00264-005-0054-y

P304

79-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

417903

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00264-005-0054-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7295429

http://www.w3.org/2001/XMLSchema#string

P6179

1028700277

http://www.w3.org/2001/XMLSchema#string

P698

16482442

http://www.w3.org/2001/XMLSchema#string

P921

P932

2532069

http://www.w3.org/2001/XMLSchema#string